CME

Markets open higher ahead of major Mag 7 earnings reports. SpaceX posts impressive Q3 results with 161% revenue growth.

Early morning earnings from NextEra Energy, Abbott Labs, and CME Group show mixed results, with Abbott declining on nutrition spinoff concerns. Meta and Tesla earnings expected after close, with Meta facing -52.4% earnings decline despite strong revenue growth, while Tesla carries a Sell rating heading into its report.

Stock futures opened higher on October 21st, 2026, as bond yields and oil prices cooled from recent highs. SpaceX surged 8% after posting impressive Q3 earnings with 161% revenue growth. Mixed earnings from NEE, ABT, and CME set the stage for major Mag 7 earnings releases after the close, with Meta and Tesla expected to report results amid ongoing market scrutiny.

CME Group delivered solid third-quarter 2026 results with revenues rising 13% to $1.73 billion and adjusted EPS increasing 12.7% to $3.02, beating consensus estimates. Record average daily volume climbed 16.3% to 29.4 million contracts across all major product lines. The company returned $1 billion to shareholders through dividends and share repurchases.

The Federal Reserve is expected to raise interest rates again by December 2026, with a 90% probability according to CME FedWatch. Rising inflation, driven primarily by fuel and gasoline prices due to the Iran war, has prompted Fed Chair Kevin Warsh to aggressively target the 2% inflation goal.

This could significantly impact markets, similar to 2022 when rate hikes caused the S&P 500 to decline over 19%. Investors are advised to diversify their portfolios, with oil and gas stocks potentially serving as hedges against current market conditions.

CME Group and Coinbase Global represent two different approaches to financial infrastructure. CME operates a high-margin derivatives marketplace with a 62% net margin and strong cash generation, while Coinbase scales rapidly in crypto trading but faces regulatory uncertainty. The author recommends CME due to its superior profitability, lower valuation multiple, dividend payment, and skepticism about crypto's fundamental value.

CME Group is expected to report Q3 2026 earnings of $2.98 per share (11.2% YoY growth) and revenues of $1.71 billion (11.4% YoY growth) on October 21. The company's Earnings ESP of +0.73% combined with a Zacks Rank #3 suggests an earnings beat. Strong trading volumes (up 16% to 29.4 million contracts) and market data revenue growth (up 16.7%) are key drivers, though expenses are expected to rise due to employee compensation and technology investments.

Zacks analyzes five securities exchange stocks amid industry headwinds. While diversified revenue streams, higher trading volumes, and technology investments support growth, the Securities and Exchanges industry faces challenges from regulatory changes, cybersecurity threats, and competition.

The industry ranks #166 out of 247 Zacks industries with negative earnings outlook, having underperformed the S&P 500 year-to-date. Five Hold-rated stocks are highlighted for consideration.

CME Group is expected to report Q3 2026 earnings of $2.96 per share (up 10.5% YoY) with revenues of $1.71 billion (up 11.4% YoY) on October 21. The company has a positive Earnings ESP of +1.56% combined with a Zacks Rank #3, suggesting a likely earnings beat. CME has beaten consensus estimates in 3 of the last 4 quarters.

CME Group's Q2 2026 average daily volume reached 29.8M contracts, down 1.2% YoY but the second-highest second-quarter level on record. Equity index and agricultural trading gains offset declines in other segments.

While CME's diversified product portfolio supports long-term volume sustainability, growth may moderate as market volatility normalizes. The stock trades at a premium valuation of 22.02x P/E versus the industry average of 20.33x.

Intercontinental Exchange (ICE) demonstrated resilience in Q2 2026 with 3% exchange revenue growth to $1.46 billion, driven by strong performance in financials (+21%), equities (+15%), and data services (+12%), offsetting a 13% decline in energy revenues. The company's shift toward recurring revenues (up 10%) and diversified asset classes positions it well for sustained growth beyond volatility spikes. Peers CME Group and Cboe Global Markets also show strong positioning with record open interest and broad product diversification.

Marex Group Limited announced that Chair Robert Pickering has stepped down after a three-year tenure that oversaw the company's transformation from a private firm to a NASDAQ-listed business with over $5 billion market capitalization. John Pietrowicz, former CFO of CME Group, has been appointed as the new Chair. The leadership transition comes as Marex continues its growth trajectory following its successful IPO in April 2024.

Cboe Global Markets has extended its exclusive licensing agreement with S&P Dow Jones Indices for SPX options through 2051. SPX options recorded record volume of 970.6 million contracts in 2025 with 25% year-over-year daily volume growth.

While the extension supports long-term revenue growth and product innovation, revised royalty terms beginning in 2027 could increase costs. Competitors CME Group and Nasdaq continue expanding their own index derivatives offerings.

The article highlights two finance stocks with positive Earnings Surprise Prediction (ESP) figures that could beat analyst expectations in their upcoming earnings reports. Arch Capital Group (ACGL) has a +24.57% ESP ahead of its October 27, 2026 earnings release, while CME Group (CME) has a +0.26% ESP before reporting on October 21, 2026. Both stocks carry a Zacks Rank #3 (Hold) rating.

Nasdaq's FinTech division is becoming a major growth driver, with revenues rising 16% to $539 million in Q2 2026 and 15% organic growth. The business spans Financial Crime Management, Regulatory Technology, and Capital Markets Technology, with strong client additions and cross-selling opportunities. Competitors ICE and CME are also expanding their technology and subscription-based offerings.

Inflation accelerated to 3.7% in September due to the Iran war disrupting oil supplies, prompting the Federal Reserve to raise interest rates and signaling more hikes ahead. Historically, new rate-hike cycles correlate with stock market corrections of 10-12%, though long-term investors should focus on quality stocks with strong fundamentals as markets have recovered from all past drawdowns.

President Trump has begun publicly criticizing Fed Chair Kevin Warsh and the FOMC for maintaining elevated interest rates, despite initially supporting Warsh's nomination. The central bank is raising rates due to 'Trumpflation' caused by tariffs and the Iran war, which have pushed inflation to a 67-month high of 4.2%. With a 64% probability of at least 75 basis points in rate hikes by September 2027, the resulting higher borrowing costs could slow AI infrastructure investment and potentially trigger a stock market correction.

The Federal Reserve's October inflation forecast shows concerning reacceleration in both headline CPI (3.77%) and Core PCE (3.13%), suggesting persistent inflation pressures beyond energy shocks. With inflation remaining above the Fed's 2% target for 67 months, the probability of multiple rate hikes reaching 4.50%-4.75% by September 2027 stands at 72%. This aggressive rate-hiking cycle poses significant risks to the historically expensive, AI-driven stock market, potentially triggering a sharp correction if borrowing costs rise and AI infrastructure spending slows.

Nasdaq reported Q3 2026 non-GAAP EPS of $1.04, up 18% YoY and beating consensus by 1.96%. Net revenues increased 13% to $1.48 billion, driven by strong Solutions and Financial Technology segments.

Operating margins expanded to 57% as the company returned $496 billion through dividends and share repurchases. Index revenues surged 39% with record ETP assets under management reaching $1.11 trillion.

Rising inflation and geopolitical tensions driving oil prices higher are prompting the Federal Reserve to continue hiking interest rates. With the S&P 500 trading at historically high valuations (CAPE ratio of 41), the market faces significant vulnerability to a sharp correction as higher rates reduce consumer spending, corporate borrowing, and stock valuations.